It has been reported that SLC7A11 is upregulated in renal cell carcinoma, and its increased expression is associated with the inferior survival of affected patients; SLC7A11 silencing is associated with decreased migration, invasion, and proliferation of malignant cells [86]. Here, SLC7A11 is linked to hereditary clear cell renal cell carcinoma.